Jpmorgan Chase & CO Haleon PLC Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Haleon PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,084,202 shares of HLN stock, worth $49.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,084,202
Previous 4,057,263
25.31%
Holding current value
$49.3 Million
Previous $33.5 Million
60.51%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HLN
# of Institutions
639Shares Held
412MCall Options Held
149KPut Options Held
16K-
Dodge & Cox San Francisco, CA179MShares$1.74 Billion1.15% of portfolio
-
Clearbridge Investments, LLC New York, NY37.4MShares$362 Million0.32% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.9MShares$241 Million1.54% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$133 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA9.15MShares$88.8 Million0.02% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.8B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...